GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 74 filers reported holding GOSSAMER BIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,156,000 | +349.3% | 513,793 | +214.0% | 0.00% | +100.0% |
| Q2 2022 | $1,370,000 | -23.2% | 163,626 | -19.8% | 0.00% | 0.0% |
| Q1 2022 | $1,784,000 | -16.1% | 203,936 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $2,127,000 | -8.9% | 206,954 | -6.8% | 0.00% | 0.0% |
| Q3 2021 | $2,335,000 | +25.9% | 221,959 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $1,854,000 | -78.8% | 228,347 | -75.8% | 0.00% | -66.7% |
| Q1 2021 | $8,735,000 | +25.8% | 944,294 | +31.5% | 0.00% | +50.0% |
| Q4 2020 | $6,945,000 | -1.5% | 718,216 | +26.4% | 0.00% | -33.3% |
| Q3 2020 | $7,054,000 | +188.2% | 568,420 | +201.9% | 0.00% | +200.0% |
| Q2 2020 | $2,448,000 | +24.6% | 188,290 | -2.8% | 0.00% | 0.0% |
| Q1 2020 | $1,965,000 | -29.5% | 193,621 | +8.6% | 0.00% | 0.0% |
| Q4 2019 | $2,786,000 | -2.8% | 178,240 | +4.4% | 0.00% | 0.0% |
| Q3 2019 | $2,866,000 | +33.1% | 170,693 | +75.8% | 0.00% | 0.0% |
| Q2 2019 | $2,153,000 | – | 97,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,758,069 | $23,085,000 | 6.16% |
| Ally Bridge Group (NY) LLC | 700,000 | $5,859,000 | 5.34% |
| Kynam Capital Management, LP | 2,350,448 | $19,673,000 | 5.02% |
| Omega Fund Management, LLC | 1,500,000 | $12,555,000 | 4.01% |
| Ikarian Capital, LLC | 1,000,387 | $8,373,000 | 1.53% |
| HHLR ADVISORS, LTD. | 7,420,974 | $62,114,000 | 1.33% |
| Boxer Capital, LLC | 2,462,358 | $20,610,000 | 1.30% |
| Palo Alto Investors LP | 1,750,651 | $14,653,000 | 1.28% |
| Artal Group S.A. | 2,358,968 | $19,745,000 | 1.06% |
| Birchview Capital, LP | 159,088 | $1,332,000 | 0.97% |